LOCK-UP AGREEMENTLock-Up Agreement • June 30th, 2020 • Orbimed Advisors LLC • Biological products, (no disgnostic substances) • New York
This LOCK-UP AGREEMENT (this “Agreement”) is made as of June 19, 2020, by and between the undersigned person or entity (the “Restricted Holder”) and Compass Therapeutics, Inc. (formerly known as Olivia Ventures, Inc.), a Delaware corporation (the “Parent”). Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Merger Agreement (as defined below).
JOINT FILING AGREEMENTJoint Filing Agreement • June 30th, 2020 • Orbimed Advisors LLC • Biological products, (no disgnostic substances)
The undersigned hereby agree that the Statement on Schedule 13D, dated June 29, 2020, with respect to the common shares of Compass Therapeutics, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
